Global Mesalazine Market Research Report 2022

Publisher Name :
Date: 14-Nov-2022
No. of pages: 108
Inquire Before Buying

This report aims to provide a comprehensive presentation of the global market for Mesalazine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mesalazine.

The Mesalazine market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Mesalazine market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Mesalazine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

- PharmaZell

- Syntese A/S

- Cambrex Corporation

- Divis Laboratories

- Chemi SpA

- Ipca Laboratories

- Hangzhou Brother

- Lianyungang Fengheng Biopharm

- Lasa Loboratory

- Corden Pharma Bergamo

- Erregierre SpA

- CTX Lifescience

- Ishita Active Pharma Ingredients

- YC Biotech (Jiangsu)

- Xinxiang Tianfeng Fine Chemical

Product Type Insights

Global markets are presented by Mesalazine type, along with growth forecasts through 2028. Estimates on sales and revenue are based on the price in the supply chain at which the Mesalazine are procured by the manufacturers.

This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).

Mesalazine segment by Purity

- Above 97 %

- Above 98 %

- Above 99 %

Application Insights

This report has provided the market size (sales and revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).

This report also outlines the market trends of each segment and consumer behaviors impacting the Mesalazine market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Mesalazine market.

Mesalazine segment by Application

- Tablets

- Capsules

- Pellet and Granule

- Suppository

- Enema

- Others

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028.

The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - China Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Mesalazine market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mesalazine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

This report will help stakeholders to understand the global industry status and trends of Mesalazine and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

This report stays updated with novel technology integration, features, and the latest developments in the market

This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Mesalazine industry.

This report helps stakeholders to gain insights into which regions to target globally

This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mesalazine.

This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Detailed analysis of Mesalazine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Sales, revenue of Mesalazine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 4: Provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 8: Analysis of sales channel, distributors and customers

Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 10: sales and revenue forecast, global and regional, by Type and by Application. It provides a quantitative analysis of the market size and development potential of each market segment in the next six years.

Chapter 11: The main points and conclusions of the report.

Global Mesalazine Market Research Report 2022

Table of Contents
1 Mesalazine Market Overview
1.1 Product Overview and Scope of Mesalazine
1.2 Mesalazine Segment by Purity
1.2.1 Global Mesalazine Sales Growth Rate Comparison by Purity (2022-2028)
1.2.2 Above 97 %
1.2.3 Above 98 %
1.2.4 Above 99 %
1.3 Mesalazine Segment by Application
1.3.1 Global Mesalazine Sales Comparison by Application: (2022-2028)
1.3.2 Tablets
1.3.3 Capsules
1.3.4 Pellet and Granule
1.3.5 Suppository
1.3.6 Enema
1.3.7 Others
1.4 Global Mesalazine Market Size Estimates and Forecasts
1.4.1 Global Mesalazine Revenue 2017-2028
1.4.2 Global Mesalazine Sales 2017-2028
1.4.3 Mesalazine Market Size by Region: 2017 Versus 2021 Versus 2028
2 Mesalazine Market Competition by Manufacturers
2.1 Global Mesalazine Sales Market Share by Manufacturers (2017-2022)
2.2 Global Mesalazine Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Mesalazine Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Mesalazine Manufacturing Sites, Area Served, Product Type
2.5 Mesalazine Market Competitive Situation and Trends
2.5.1 Mesalazine Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Mesalazine Players Market Share by Revenue
2.5.3 Global Mesalazine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Mesalazine Retrospective Market Scenario by Region
3.1 Global Mesalazine Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Mesalazine Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Mesalazine Market Facts & Figures by Country
3.3.1 North America Mesalazine Sales by Country
3.3.2 North America Mesalazine Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Mesalazine Market Facts & Figures by Country
3.4.1 Europe Mesalazine Sales by Country
3.4.2 Europe Mesalazine Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Mesalazine Market Facts & Figures by Region
3.5.1 Asia Pacific Mesalazine Sales by Region
3.5.2 Asia Pacific Mesalazine Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Mesalazine Market Facts & Figures by Country
3.6.1 Latin America Mesalazine Sales by Country
3.6.2 Latin America Mesalazine Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Mesalazine Market Facts & Figures by Country
3.7.1 Middle East and Africa Mesalazine Sales by Country
3.7.2 Middle East and Africa Mesalazine Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Mesalazine Historic Market Analysis by Purity
4.1 Global Mesalazine Sales Market Share by Purity (2017-2022)
4.2 Global Mesalazine Revenue Market Share by Purity (2017-2022)
4.3 Global Mesalazine Price by Purity (2017-2022)
5 Global Mesalazine Historic Market Analysis by Application
5.1 Global Mesalazine Sales Market Share by Application (2017-2022)
5.2 Global Mesalazine Revenue Market Share by Application (2017-2022)
5.3 Global Mesalazine Price by Application (2017-2022)
6 Key Companies Profiled
6.1 PharmaZell
6.1.1 PharmaZell Corporation Information
6.1.2 PharmaZell Description and Business Overview
6.1.3 PharmaZell Mesalazine Sales, Revenue and Gross Margin (2017-2022)
6.1.4 PharmaZell Mesalazine Product Portfolio
6.1.5 PharmaZell Recent Developments/Updates
6.2 Syntese A/S
6.2.1 Syntese A/S Corporation Information
6.2.2 Syntese A/S Description and Business Overview
6.2.3 Syntese A/S Mesalazine Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Syntese A/S Mesalazine Product Portfolio
6.2.5 Syntese A/S Recent Developments/Updates
6.3 Cambrex Corporation
6.3.1 Cambrex Corporation Corporation Information
6.3.2 Cambrex Corporation Description and Business Overview
6.3.3 Cambrex Corporation Mesalazine Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Cambrex Corporation Mesalazine Product Portfolio
6.3.5 Cambrex Corporation Recent Developments/Updates
6.4 Divis Laboratories
6.4.1 Divis Laboratories Corporation Information
6.4.2 Divis Laboratories Description and Business Overview
6.4.3 Divis Laboratories Mesalazine Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Divis Laboratories Mesalazine Product Portfolio
6.4.5 Divis Laboratories Recent Developments/Updates
6.5 Chemi SpA
6.5.1 Chemi SpA Corporation Information
6.5.2 Chemi SpA Description and Business Overview
6.5.3 Chemi SpA Mesalazine Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Chemi SpA Mesalazine Product Portfolio
6.5.5 Chemi SpA Recent Developments/Updates
6.6 Ipca Laboratories
6.6.1 Ipca Laboratories Corporation Information
6.6.2 Ipca Laboratories Description and Business Overview
6.6.3 Ipca Laboratories Mesalazine Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Ipca Laboratories Mesalazine Product Portfolio
6.6.5 Ipca Laboratories Recent Developments/Updates
6.7 Hangzhou Brother
6.6.1 Hangzhou Brother Corporation Information
6.6.2 Hangzhou Brother Description and Business Overview
6.6.3 Hangzhou Brother Mesalazine Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Hangzhou Brother Mesalazine Product Portfolio
6.7.5 Hangzhou Brother Recent Developments/Updates
6.8 Lianyungang Fengheng Biopharm
6.8.1 Lianyungang Fengheng Biopharm Corporation Information
6.8.2 Lianyungang Fengheng Biopharm Description and Business Overview
6.8.3 Lianyungang Fengheng Biopharm Mesalazine Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Lianyungang Fengheng Biopharm Mesalazine Product Portfolio
6.8.5 Lianyungang Fengheng Biopharm Recent Developments/Updates
6.9 Lasa Loboratory
6.9.1 Lasa Loboratory Corporation Information
6.9.2 Lasa Loboratory Description and Business Overview
6.9.3 Lasa Loboratory Mesalazine Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Lasa Loboratory Mesalazine Product Portfolio
6.9.5 Lasa Loboratory Recent Developments/Updates
6.10 Corden Pharma Bergamo
6.10.1 Corden Pharma Bergamo Corporation Information
6.10.2 Corden Pharma Bergamo Description and Business Overview
6.10.3 Corden Pharma Bergamo Mesalazine Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Corden Pharma Bergamo Mesalazine Product Portfolio
6.10.5 Corden Pharma Bergamo Recent Developments/Updates
6.11 Erregierre SpA
6.11.1 Erregierre SpA Corporation Information
6.11.2 Erregierre SpA Mesalazine Description and Business Overview
6.11.3 Erregierre SpA Mesalazine Sales, Revenue and Gross Margin (2017-2022)
6.11.4 Erregierre SpA Mesalazine Product Portfolio
6.11.5 Erregierre SpA Recent Developments/Updates
6.12 CTX Lifescience
6.12.1 CTX Lifescience Corporation Information
6.12.2 CTX Lifescience Mesalazine Description and Business Overview
6.12.3 CTX Lifescience Mesalazine Sales, Revenue and Gross Margin (2017-2022)
6.12.4 CTX Lifescience Mesalazine Product Portfolio
6.12.5 CTX Lifescience Recent Developments/Updates
6.13 Ishita Active Pharma Ingredients
6.13.1 Ishita Active Pharma Ingredients Corporation Information
6.13.2 Ishita Active Pharma Ingredients Mesalazine Description and Business Overview
6.13.3 Ishita Active Pharma Ingredients Mesalazine Sales, Revenue and Gross Margin (2017-2022)
6.13.4 Ishita Active Pharma Ingredients Mesalazine Product Portfolio
6.13.5 Ishita Active Pharma Ingredients Recent Developments/Updates
6.14 YC Biotech (Jiangsu)
6.14.1 YC Biotech (Jiangsu) Corporation Information
6.14.2 YC Biotech (Jiangsu) Mesalazine Description and Business Overview
6.14.3 YC Biotech (Jiangsu) Mesalazine Sales, Revenue and Gross Margin (2017-2022)
6.14.4 YC Biotech (Jiangsu) Mesalazine Product Portfolio
6.14.5 YC Biotech (Jiangsu) Recent Developments/Updates
6.15 Xinxiang Tianfeng Fine Chemical
6.15.1 Xinxiang Tianfeng Fine Chemical Corporation Information
6.15.2 Xinxiang Tianfeng Fine Chemical Mesalazine Description and Business Overview
6.15.3 Xinxiang Tianfeng Fine Chemical Mesalazine Sales, Revenue and Gross Margin (2017-2022)
6.15.4 Xinxiang Tianfeng Fine Chemical Mesalazine Product Portfolio
6.15.5 Xinxiang Tianfeng Fine Chemical Recent Developments/Updates
7 Mesalazine Manufacturing Cost Analysis
7.1 Mesalazine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Mesalazine
7.4 Mesalazine Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Mesalazine Distributors List
8.3 Mesalazine Customers
9 Mesalazine Market Dynamics
9.1 Mesalazine Industry Trends
9.2 Mesalazine Market Drivers
9.3 Mesalazine Market Challenges
9.4 Mesalazine Market Restraints
10 Global Market Forecast
10.1 Mesalazine Market Estimates and Projections by Purity
10.1.1 Global Forecasted Sales of Mesalazine by Purity (2023-2028)
10.1.2 Global Forecasted Revenue of Mesalazine by Purity (2023-2028)
10.2 Mesalazine Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Mesalazine by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Mesalazine by Application (2023-2028)
10.3 Mesalazine Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Mesalazine by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Mesalazine by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Mesalazine Sales Growth Rate Comparison by Purity (2022-2028) & (Tons) & (US$ Million)
Table 2. Global Mesalazine Sales Growth Rate Comparison by Application (2022-2028) & (Tons) & (US$ Million)
Table 3. Global Mesalazine Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Mesalazine Market Competitive Situation by Manufacturers in 2021
Table 5. Global Mesalazine Sales (Tons) of Key Manufacturers (2017-2022)
Table 6. Global Mesalazine Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Mesalazine Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Mesalazine Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Mesalazine Average Price (US$/Ton) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Mesalazine Manufacturing Sites and Area Served
Table 11. Manufacturers Mesalazine Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Mesalazine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Mesalazine as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Mesalazine Sales by Region (2017-2022) & (Tons)
Table 16. Global Mesalazine Sales Market Share by Region (2017-2022)
Table 17. Global Mesalazine Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Mesalazine Revenue Market Share by Region (2017-2022)
Table 19. North America Mesalazine Sales by Country (2017-2022) & (Tons)
Table 20. North America Mesalazine Sales Market Share by Country (2017-2022)
Table 21. North America Mesalazine Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Mesalazine Revenue Market Share by Country (2017-2022)
Table 23. Europe Mesalazine Sales by Country (2017-2022) & (Tons)
Table 24. Europe Mesalazine Sales Market Share by Country (2017-2022)
Table 25. Europe Mesalazine Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Mesalazine Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Mesalazine Sales by Region (2017-2022) & (Tons)
Table 28. Asia Pacific Mesalazine Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Mesalazine Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Mesalazine Revenue Market Share by Region (2017-2022)
Table 31. Latin America Mesalazine Sales by Country (2017-2022) & (Tons)
Table 32. Latin America Mesalazine Sales Market Share by Country (2017-2022)
Table 33. Latin America Mesalazine Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Mesalazine Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Mesalazine Sales by Country (2017-2022) & (Tons)
Table 36. Middle East and Africa Mesalazine Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Mesalazine Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Mesalazine Revenue Market Share by Country (2017-2022)
Table 39. Global Mesalazine Sales by Purity (2017-2022) & (Tons)
Table 40. Global Mesalazine Sales Market Share by Purity (2017-2022)
Table 41. Global Mesalazine Revenue by Purity (2017-2022) & (US$ Million)
Table 42. Global Mesalazine Revenue Share by Purity (2017-2022)
Table 43. Global Mesalazine Price by Purity (2017-2022) & (US$/Ton)
Table 44. Global Mesalazine Sales (Tons) by Application (2017-2022)
Table 45. Global Mesalazine Sales Market Share by Application (2017-2022)
Table 46. Global Mesalazine Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Mesalazine Revenue Share by Application (2017-2022)
Table 48. Global Mesalazine Price by Application (2017-2022) & (US$/Ton)
Table 49. PharmaZell Corporation Information
Table 50. PharmaZell Description and Business Overview
Table 51. PharmaZell Mesalazine Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 52. PharmaZell Mesalazine Product
Table 53. PharmaZell Recent Developments/Updates
Table 54. Syntese A/S Corporation Information
Table 55. Syntese A/S Description and Business Overview
Table 56. Syntese A/S Mesalazine Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 57. Syntese A/S Mesalazine Product
Table 58. Syntese A/S Recent Developments/Updates
Table 59. Cambrex Corporation Corporation Information
Table 60. Cambrex Corporation Description and Business Overview
Table 61. Cambrex Corporation Mesalazine Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 62. Cambrex Corporation Mesalazine Product
Table 63. Cambrex Corporation Recent Developments/Updates
Table 64. Divis Laboratories Corporation Information
Table 65. Divis Laboratories Description and Business Overview
Table 66. Divis Laboratories Mesalazine Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 67. Divis Laboratories Mesalazine Product
Table 68. Divis Laboratories Recent Developments/Updates
Table 69. Chemi SpA Corporation Information
Table 70. Chemi SpA Description and Business Overview
Table 71. Chemi SpA Mesalazine Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 72. Chemi SpA Mesalazine Product
Table 73. Chemi SpA Recent Developments/Updates
Table 74. Ipca Laboratories Corporation Information
Table 75. Ipca Laboratories Description and Business Overview
Table 76. Ipca Laboratories Mesalazine Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 77. Ipca Laboratories Mesalazine Product
Table 78. Ipca Laboratories Recent Developments/Updates
Table 79. Hangzhou Brother Corporation Information
Table 80. Hangzhou Brother Description and Business Overview
Table 81. Hangzhou Brother Mesalazine Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 82. Hangzhou Brother Mesalazine Product
Table 83. Hangzhou Brother Recent Developments/Updates
Table 84. Lianyungang Fengheng Biopharm Corporation Information
Table 85. Lianyungang Fengheng Biopharm Description and Business Overview
Table 86. Lianyungang Fengheng Biopharm Mesalazine Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 87. Lianyungang Fengheng Biopharm Mesalazine Product
Table 88. Lianyungang Fengheng Biopharm Recent Developments/Updates
Table 89. Lasa Loboratory Corporation Information
Table 90. Lasa Loboratory Description and Business Overview
Table 91. Lasa Loboratory Mesalazine Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 92. Lasa Loboratory Mesalazine Product
Table 93. Lasa Loboratory Recent Developments/Updates
Table 94. Corden Pharma Bergamo Corporation Information
Table 95. Corden Pharma Bergamo Description and Business Overview
Table 96. Corden Pharma Bergamo Mesalazine Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 97. Corden Pharma Bergamo Mesalazine Product
Table 98. Corden Pharma Bergamo Recent Developments/Updates
Table 99. Erregierre SpA Corporation Information
Table 100. Erregierre SpA Description and Business Overview
Table 101. Erregierre SpA Mesalazine Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 102. Erregierre SpA Mesalazine Product
Table 103. Erregierre SpA Recent Developments/Updates
Table 104. CTX Lifescience Corporation Information
Table 105. CTX Lifescience Description and Business Overview
Table 106. CTX Lifescience Mesalazine Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 107. CTX Lifescience Mesalazine Product
Table 108. CTX Lifescience Recent Developments/Updates
Table 109. Ishita Active Pharma Ingredients Corporation Information
Table 110. Ishita Active Pharma Ingredients Description and Business Overview
Table 111. Ishita Active Pharma Ingredients Mesalazine Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 112. Ishita Active Pharma Ingredients Mesalazine Product
Table 113. Ishita Active Pharma Ingredients Recent Developments/Updates
Table 114. YC Biotech (Jiangsu) Corporation Information
Table 115. YC Biotech (Jiangsu) Description and Business Overview
Table 116. YC Biotech (Jiangsu) Mesalazine Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 117. YC Biotech (Jiangsu) Mesalazine Product
Table 118. YC Biotech (Jiangsu) Recent Developments/Updates
Table 119. Xinxiang Tianfeng Fine Chemical Corporation Information
Table 120. Xinxiang Tianfeng Fine Chemical Description and Business Overview
Table 121. Xinxiang Tianfeng Fine Chemical Mesalazine Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 122. Xinxiang Tianfeng Fine Chemical Mesalazine Product
Table 123. Xinxiang Tianfeng Fine Chemical Recent Developments/Updates
Table 124. Production Base and Market Concentration Rate of Raw Material
Table 125. Key Suppliers of Raw Materials
Table 126. Mesalazine Distributors List
Table 127. Mesalazine Customers List
Table 128. Mesalazine Market Trends
Table 129. Mesalazine Market Drivers
Table 130. Mesalazine Market Challenges
Table 131. Mesalazine Market Restraints
Table 132. Global Mesalazine Sales Forecast by Purity (2023-2028) & (Tons)
Table 133. Global Mesalazine Sales Market Share Forecast by Purity (2023-2028)
Table 134. Global Mesalazine Revenue Forecast by Purity (2023-2028) & (US$ Million)
Table 135. Global Mesalazine Revenue Market Share Forecast by Purity (2023-2028)
Table 136. Global Mesalazine Sales Forecast by Application (2023-2028) & (Tons)
Table 137. Global Mesalazine Sales Market Share Forecast by Application (2023-2028)
Table 138. Global Mesalazine Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 139. Global Mesalazine Revenue Market Share Forecast by Application (2023-2028)
Table 140. Global Mesalazine Sales Forecast by Region (2023-2028) & (Tons)
Table 141. Global Mesalazine Sales Market Share Forecast by Region (2023-2028)
Table 142. Global Mesalazine Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 143. Global Mesalazine Revenue Market Share Forecast by Region (2023-2028)
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Mesalazine
Figure 2. Global Mesalazine Market Share by Purity in 2021 & 2028
Figure 3. Above 97 % Product Picture
Figure 4. Above 98 % Product Picture
Figure 5. Above 99 % Product Picture
Figure 6. Global Mesalazine Market Share by Application in 2021 & 2028
Figure 7. Tablets
Figure 8. Capsules
Figure 9. Pellet and Granule
Figure 10. Suppository
Figure 11. Enema
Figure 12. Others
Figure 13. Global Mesalazine Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Mesalazine Market Size (2017-2028) & (US$ Million)
Figure 15. Global Mesalazine Sales (2017-2028) & (Tons)
Figure 16. Mesalazine Sales Share by Manufacturers in 2021
Figure 17. Global Mesalazine Revenue Share by Manufacturers in 2021
Figure 18. The Global 5 and 10 Largest Mesalazine Players: Market Share by Revenue in 2021
Figure 19. Mesalazine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 20. Global Mesalazine Sales Market Share by Region (2017-2022)
Figure 21. Global Mesalazine Sales Market Share by Region in 2021
Figure 22. Global Mesalazine Revenue Market Share by Region (2017-2022)
Figure 23. Global Mesalazine Revenue Market Share by Region in 2021
Figure 24. U.S. Mesalazine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. Canada Mesalazine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. Germany Mesalazine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. France Mesalazine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. U.K. Mesalazine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. Italy Mesalazine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. Russia Mesalazine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. China Mesalazine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. Japan Mesalazine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. South Korea Mesalazine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. India Mesalazine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Australia Mesalazine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. China Taiwan Mesalazine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Indonesia Mesalazine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Thailand Mesalazine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Malaysia Mesalazine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Mexico Mesalazine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Brazil Mesalazine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Argentina Mesalazine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. Turkey Mesalazine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 44. Saudi Arabia Mesalazine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 45. UAE Mesalazine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 46. Sales Market Share of Mesalazine by Purity (2017-2022)
Figure 47. Manufacturing Cost Structure of Mesalazine
Figure 48. Manufacturing Process Analysis of Mesalazine
Figure 49. Mesalazine Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
  • Global Methylprednisolone Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    Methylprednisolone is a corticosteroid medication used to reduce inflammation and suppress The immune system. It is prescribed for a wide range of medical conditions, including autoimmune disorders and inflammatory diseases. The global Methylprednisolone market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. Methylprednisolone is a widely used medication, and The market trend invol......
  • Global Ibuprofen Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 84
    Ibuprofen is an API which is used to produce ibuprofen drugs. Finished drugs ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) derivative of propionic acid used for relieving pain, helping with fever and reducing inflammation. The global Ibuprofen market was valued at US$ 93 million in 2023 and is anticipated to reach US$ 112.3 million by 2030, witnessing a CAGR of 2.7% during The forecast period 2024-2030. Market competition is intense. Xinhua Pharmaceutical, IOLCP,......
  • Global Mesalazine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 132
    According to our LPI (LP Information) latest study, the global Mesalazine market size was valued at US$ 158.3 million in 2023. With growing demand in downstream market, the Mesalazine is forecast to a readjusted size of US$ 206 million by 2030 with a CAGR of 3.8% during review period. The research report highlights the growth potential of the global Mesalazine market. Mesalazine are expected to show stable growth in the future market. However, product differentiation, reducing costs, and......
  • Global Drugs For Sinusitis Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 109
    According to our LPI (LP Information) latest study, the global Drugs For Sinusitis market size was valued at US$ 2187.4 million in 2023. With growing demand in downstream market, the Drugs For Sinusitis is forecast to a readjusted size of US$ 2827.4 million by 2030 with a CAGR of 3.7% during review period. The research report highlights the growth potential of the global Drugs For Sinusitis market. Drugs For Sinusitis are expected to show stable growth in the future market. However, prod......
  • Global Celecoxib Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 94
    According to our LPI (LP Information) latest study, the global Celecoxib market size was valued at US$ 1243.6 million in 2023. With growing demand in downstream market, the Celecoxib is forecast to a readjusted size of US$ 2232 million by 2030 with a CAGR of 8.7% during review period. The research report highlights the growth potential of the global Celecoxib market. Celecoxib are expected to show stable growth in the future market. However, product differentiation, reducing costs, and s......
  • Global Ibuprofen Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 100
    According to our LPI (LP Information) latest study, the global Ibuprofen market size was valued at US$ 91 million in 2023. With growing demand in downstream market, the Ibuprofen is forecast to a readjusted size of US$ 110.4 million by 2030 with a CAGR of 2.8% during review period. The research report highlights the growth potential of the global Ibuprofen market. Ibuprofen are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supp......
  • Global Ketoprofen Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 94
    According to our LPI (LP Information) latest study, the global Ketoprofen market size was valued at US$ 34 million in 2023. With growing demand in downstream market, the Ketoprofen is forecast to a readjusted size of US$ 39 million by 2030 with a CAGR of 2.0% during review period. The research report highlights the growth potential of the global Ketoprofen market. Ketoprofen are expected to show stable growth in the future market. However, product differentiation, reducing costs, and sup......
  • Global Drugs for Sinusitis Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 02-Jan-2024        Price: US 3380 Onwards        Pages: 114
    Market Overview of Global Drugs for Sinusitis market: According to our latest research, the global Drugs for Sinusitis market looks promising in the next 5 years. As of 2022, the global Drugs for Sinusitis market was estimated at USD 2147.6 million, and it's anticipated to reach USD 3206.59 million in 2028, with a CAGR of 6.91% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Dru......
  • Global Ibuprofen Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 91
    According to our (Global Info Research) latest study, the global Ibuprofen market size was valued at USD 96 million in 2023 and is forecast to a readjusted size of USD 114.4 million by 2030 with a CAGR of 2.6% during review period. Ibuprofen is an API which is used to produce ibuprofen drugs. Finished drugs ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) derivative of propionic acid used for relieving pain, helping with fever and reducing inflammation. Market competitio......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs